These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 4383660)
21. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy. Hendley ED; Snyder SH Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350 [No Abstract] [Full Text] [Related]
22. Some antagonists of the monoamine oxidase inhibitors. HORITA A Ann N Y Acad Sci; 1963 Jul; 107():951-7. PubMed ID: 13954907 [No Abstract] [Full Text] [Related]
23. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain. Yamada N; Takahashi S; Todd KG; Baker GB; Paetsch PR J Pharm Sci; 1993 Sep; 82(9):934-7. PubMed ID: 7901387 [TBL] [Abstract][Full Text] [Related]
24. [ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS]. HORNYKIEWICZ O Wien Klin Wochenschr; 1964 Apr; 76():289-93. PubMed ID: 14223504 [No Abstract] [Full Text] [Related]
25. CHEESE AND MONOAMINE OXIDASE INHIBITORS. INTERACTION IN ANAESTHETISED CATS. NATOFF IL Lancet; 1964 Mar; 1(7332):532-3. PubMed ID: 14100189 [No Abstract] [Full Text] [Related]
26. The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine-treated mice. Carlsson A; Waldeck B J Pharm Pharmacol; 1967 Mar; 19(3):182-90. PubMed ID: 4382340 [No Abstract] [Full Text] [Related]
27. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines. Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601 [No Abstract] [Full Text] [Related]
28. [Relation between the anti-inflammatory effect and inhibiting activity of monoaminoxidase inhibitors]. Trinus FP; Riabukha TK Farmakol Toksikol; 1973; 36(1):84-9. PubMed ID: 4685161 [No Abstract] [Full Text] [Related]
30. Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor (MAOI) drugs. Trinker FR; Fearn H; McCulloch MW; Rand MJ Aust Dent J; 1967 Aug; 12(4):297-303. PubMed ID: 5233628 [No Abstract] [Full Text] [Related]
31. [New data on monoamine oxidase inhibitors]. Gorkin VZ Vestn Akad Med Nauk SSSR; 1971; 26(11):23-8. PubMed ID: 4942003 [No Abstract] [Full Text] [Related]
32. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid. MaƮtre L J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494 [No Abstract] [Full Text] [Related]
33. The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice. Rogers KJ; Thornton JA Br J Pharmacol; 1969 Jul; 36(3):470-80. PubMed ID: 5789805 [TBL] [Abstract][Full Text] [Related]
34. Monoamine oxidase and cerebral uptake of dopaminergic drugs. Cotzias GC; Tang LC; Ginos JZ Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2715-9. PubMed ID: 4137067 [TBL] [Abstract][Full Text] [Related]
35. Modaline and locomotor activity in the mouse. Gylys JA; Muccia PM Arch Int Pharmacodyn Ther; 1967 Apr; 166(2):449-65. PubMed ID: 4382254 [No Abstract] [Full Text] [Related]
36. [Inhibition by monoamine oxidase inhibitors of substrate induction of liver tryptophan pyrrolase and increase in brain serotonin]. Samsonova ML; Oksenkrug GF Vopr Med Khim; 1972; 18(2):198-202. PubMed ID: 4679586 [No Abstract] [Full Text] [Related]
37. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin]. Mal'tseva LF Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590 [No Abstract] [Full Text] [Related]
38. [Behavioral modifications observed following repeated administrations of monoamine oxidase inhibitors]. Goldwurm GF; Torrigiani G Riv Neurobiol; 1964; 10(4):Suppl:1099-106. PubMed ID: 5827089 [No Abstract] [Full Text] [Related]